However, despite the integral pathologic role of hepatic inflammation in NAFLD/NASH and the abundance of CYP enzyme expression in the liver, the contribution of CYP-mediated eicosanoid metabolism to the pathogenesis and progression of this emerging public health problem remains largely unexplored. Here, PPIG is linked to metabolic dysfunction-associated steatohepatitis.